Back to search

Norway· NO-ID_DFCAA832-96BF-4096-8D57-52BBFA89AC13

Cefotaxim Navamedic

A cefotaxime product containing cefotaxime, registered in Norway by Navamedic ASA. The same ATC class is registered in 18 of our 19 countries.

ATC J01DD01

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedCefotaxim NavamedicATCJ01DD01REGISTER NO.NO-ID_DFCAA832-96BF-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Cefotaxime is registered in 18 of 19 countries.

Countries holding a registration under ATC J01DD01 (cefotaxime), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 10 of them publish a price we can compare per daily dose

Cefotaxime · ATC J01DD01

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cefotaxime costs, country by country.

Normalised to the WHO defined daily dose (4 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Cefotaxime · price per daily dose (4 g)

USD · FX 28 Sept 2026

  • ES Spain$14.21
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Cefotaxime
Manufacturer
Navamedic ASA
Country
Norway (NO)
ATC code
J01DD01
ATC class
Cefotaxime
Defined daily dose
4 g, P
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

1 priced
  • no_merkevare_id
    ID_DFCAA832-96BF-4096-8D57-52BBFA89AC13
  • no_varenummer
    098483
    10 x 0.5
    NOK 240.3
  • gtin
    7070844900944

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

104 interactions on record for cefotaxime.

Graded by severity as the source publishes them — 21 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cefotaxime · interactions on record

104 records

  • 21 moderate
  • 83 info

Most severe, free to view

  • Sodium picosulfateA06AB08moderate
  • NeomycinA07AA01moderate
  • StreptomycinA07AA04moderate
  • KanamycinA07AA08moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cefotaxime in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cefotaxime products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Cefotaxim Aptapharma, Cefotaxim Eberth
  • Belgium · Cefotaxime Noridem, Claforan
  • Bulgaria · Валоран, Тенатаксим
  • Cyprus · Oximezin, Syntoxime
  • Czechia · Cefotaxim Hameln, Cefotaxime Swyssi
  • Germany · Cefotaxim Eberth, Cefotaxim Fresenius
  • Denmark · Cefotaxim "hameln", Cefotaxim Mip
  • Estonia · Cefotaxime Mip, Valoran
  • Spain · Cefotaxima Normon, Cefotaxima Sala
  • Finland · Cefotaxim Hameln, Cefotaxim Mip Pharma
  • France · Cefotaxime Noridem, Cefotaxime Panpharma
  • United Kingdom (Northern Ireland) · Cefotaxime Cox Pharmaceutical, Cefotaxime Hameln Pharma
  • Greece · Ciltiren, Gloryfen
  • Croatia · Cefotaksim Aptapharma, Cefotaksim Mip
  • Hungary · Cefotaxim Aptapharma, Cefotaxime Swyssi
  • Ireland · Cefotaxime Hameln, Cefotaxime Noridem Enterprises
  • Iceland · Cefotaxim Navamedic
  • Italy · Batixim, Cefotaxim Hameln
  • Lithuania · Cefotaxime Mip
  • Luxembourg · Cefotaxime Noridem, Claforan
  • Latvia · Cefotaxime Mip
  • Malta · Valoran
  • Netherlands · Cefotaxim Hameln
  • Poland · Biotaksym, Cefotaxim Mip
  • Portugal · Antadar, Antadar I.M.
  • Romania · Cefotax, Cefotaxim Mip
  • Sweden · Cefotaxim Hameln, Cefotaxim Mip
  • Slovenia · Cefotaksim Aptapharma, Valoran
  • Slovakia · Cefotaxim Eberth, Cefotaxime Hameln

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b83667fc-9727-431e-8cfb-310e3795ae7b
GET /v1/drugs/b83667fc-9727-431e-8cfb-310e3795ae7b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Pulver til injeksjonsvæske, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Cefotaksim",
  "merkevare_id": "ID_DFCAA832-96BF-4096-8D57-52BBFA89AC13",
  "name_form_strength": "Cefotaxim Navamedic pulv til inj væske, oppl 0,5 g",
  "prescription_group": "C"
}

See everything about cefotaxime.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.